Home / Drugs / valrubicin

valrubicin

FDA Drug Profile — Valstar

Drug Details

Generic Name
valrubicin
Brand Names
Valstar
Application Number
NDA020892
Sponsor
Endo USA, Inc.
NDC Codes
1
Dosage Forms
SOLUTION, CONCENTRATE
Routes
INTRAVESICAL
Active Ingredients
VALRUBICIN

Indications and Usage

1 INDICATIONS AND USAGE VALSTAR is an anthracycline topoisomerase inhibitor indicated for intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality. VALSTAR is an anthracycline topoisomerase inhibitor indicated for intravesical therapy of BCG-refractory carcinoma in situ (CIS) of the urinary bladder in patients for whom immediate cystectomy would be associated with unacceptable morbidity or mortality. ( 1 )